Chemical materials

MEDI-3617 (anti-ANGPT2)

MEDI-3617 (anti-ANGPT2)

AL-AB183134 / 100ΜG
Add to Inquiry
GSK933776 (anti-Amyloid Beta)

GSK933776 (anti-Amyloid Beta)

AL-AB183135 / 1MG
Add to Inquiry
GSK933776 (anti-Amyloid Beta)

GSK933776 (anti-Amyloid Beta)

AL-AB183135 / 5MG
Add to Inquiry
GSK933776 (anti-Amyloid Beta)

GSK933776 (anti-Amyloid Beta)

AL-AB183135 / 10MG
Add to Inquiry
GSK933776 (anti-Amyloid Beta)

GSK933776 (anti-Amyloid Beta)

AL-AB183135 / 100ΜG
Add to Inquiry
CDP-484 (anti-IL-1 beta)

CDP-484 (anti-IL-1 beta)

AL-AB183225 / 100ΜG
Add to Inquiry
CDP-484 (anti-IL-1 beta)

CDP-484 (anti-IL-1 beta)

AL-AB183225 / 10MG
Add to Inquiry
CDP-484 (anti-IL-1 beta)

CDP-484 (anti-IL-1 beta)

AL-AB183225 / 5MG
Add to Inquiry
CDP-484 (anti-IL-1 beta)

CDP-484 (anti-IL-1 beta)

AL-AB183225 / 1MG
Add to Inquiry
GSK-679586 (anti-IL-13)

GSK-679586 (anti-IL-13)

AL-AB183228 / 1MG
Add to Inquiry
GSK-679586 (anti-IL-13)

GSK-679586 (anti-IL-13)

AL-AB183228 / 5MG
Add to Inquiry
GSK-679586 (anti-IL-13)

GSK-679586 (anti-IL-13)

AL-AB183228 / 10MG
Add to Inquiry
GSK-679586 (anti-IL-13)

GSK-679586 (anti-IL-13)

AL-AB183228 / 100ΜG
Add to Inquiry
Dectrekumab (anti-IL-13)

Dectrekumab (anti-IL-13)

AL-AB183230 / 10MG
CAS No.:1528523-94-5
Add to Inquiry
Dectrekumab (anti-IL-13)

Dectrekumab (anti-IL-13)

AL-AB183230 / 100ΜG
CAS No.:1528523-94-5
Add to Inquiry
Dectrekumab (anti-IL-13)

Dectrekumab (anti-IL-13)

AL-AB183230 / 5MG
CAS No.:1528523-94-5
Add to Inquiry
Dectrekumab (anti-IL-13)

Dectrekumab (anti-IL-13)

AL-AB183230 / 1MG
CAS No.:1528523-94-5
Add to Inquiry
RG-7652 (anti-PCSK9)

RG-7652 (anti-PCSK9)

AL-AB183277 / 10MG
Add to Inquiry
RG-7652 (anti-PCSK9)

RG-7652 (anti-PCSK9)

AL-AB183277 / 100ΜG
Add to Inquiry
RG-7652 (anti-PCSK9)

RG-7652 (anti-PCSK9)

AL-AB183277 / 1MG
Add to Inquiry
RG-7652 (anti-PCSK9)

RG-7652 (anti-PCSK9)

AL-AB183277 / 5MG
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2)

Trastuzumab deruxtecan (anti-ERBB2)

AL-AB183313 / 10MG
CAS No.:1826843-81-5
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2)

Trastuzumab deruxtecan (anti-ERBB2)

AL-AB183313 / 1MG
CAS No.:1826843-81-5
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2)

Trastuzumab deruxtecan (anti-ERBB2)

AL-AB183313 / 100ΜG
CAS No.:1826843-81-5
Add to Inquiry
Trastuzumab deruxtecan (anti-ERBB2)

Trastuzumab deruxtecan (anti-ERBB2)

AL-AB183313 / 5MG
CAS No.:1826843-81-5
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2)

Datopotamab deruxtecan (anti-TROP2)

AL-AB183314 / 1MG
CAS No.:2238831-60-0
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2)

Datopotamab deruxtecan (anti-TROP2)

AL-AB183314 / 10MG
CAS No.:2238831-60-0
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2)

Datopotamab deruxtecan (anti-TROP2)

AL-AB183314 / 100ΜG
CAS No.:2238831-60-0
Add to Inquiry
Datopotamab deruxtecan (anti-TROP2)

Datopotamab deruxtecan (anti-TROP2)

AL-AB183314 / 5MG
CAS No.:2238831-60-0
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3)

Patritumab deruxtecan (anti-ERBB3)

AL-AB183315 / 1MG
CAS No.:2227102-46-5
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3)

Patritumab deruxtecan (anti-ERBB3)

AL-AB183315 / 5MG
CAS No.:2227102-46-5
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3)

Patritumab deruxtecan (anti-ERBB3)

AL-AB183315 / 10MG
CAS No.:2227102-46-5
Add to Inquiry
Patritumab deruxtecan (anti-ERBB3)

Patritumab deruxtecan (anti-ERBB3)

AL-AB183315 / 100ΜG
CAS No.:2227102-46-5
Add to Inquiry
Disitamab vedotin (anti-HER2)

Disitamab vedotin (anti-HER2)

AL-AB183317 / 10MG
CAS No.:2136633-23-1
Add to Inquiry
Disitamab vedotin (anti-HER2)

Disitamab vedotin (anti-HER2)

AL-AB183317 / 5MG
CAS No.:2136633-23-1
Add to Inquiry
Disitamab vedotin (anti-HER2)

Disitamab vedotin (anti-HER2)

AL-AB183317 / 1MG
CAS No.:2136633-23-1
Add to Inquiry
Disitamab vedotin (anti-HER2)

Disitamab vedotin (anti-HER2)

AL-AB183317 / 100ΜG
CAS No.:2136633-23-1
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1)

Farletuzumab-MMAE (anti-FOLR1)

AL-AB183319 / 10MG
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1)

Farletuzumab-MMAE (anti-FOLR1)

AL-AB183319 / 5MG
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1)

Farletuzumab-MMAE (anti-FOLR1)

AL-AB183319 / 1MG
Add to Inquiry
Farletuzumab-MMAE (anti-FOLR1)

Farletuzumab-MMAE (anti-FOLR1)

AL-AB183319 / 100ΜG
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b)

Iladatuzumab vedotin (anti-CD79b)

AL-AB183320 / 1MG
CAS No.:1906205-77-3
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b)

Iladatuzumab vedotin (anti-CD79b)

AL-AB183320 / 5MG
CAS No.:1906205-77-3
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b)

Iladatuzumab vedotin (anti-CD79b)

AL-AB183320 / 10MG
CAS No.:1906205-77-3
Add to Inquiry
Iladatuzumab vedotin (anti-CD79b)

Iladatuzumab vedotin (anti-CD79b)

AL-AB183320 / 100ΜG
CAS No.:1906205-77-3
Add to Inquiry
Zilovertamab vedotin (anti-ROR1)

Zilovertamab vedotin (anti-ROR1)

AL-AB183321 / 100ΜG
Add to Inquiry
Zilovertamab vedotin (anti-ROR1)
Add to Inquiry
Zilovertamab vedotin (anti-ROR1)
Add to Inquiry
Zilovertamab vedotin (anti-ROR1)
Add to Inquiry
Ozuriftamab vedotin (anti-ROR2)

Ozuriftamab vedotin (anti-ROR2)

AL-AB183322 / 5MG
CAS No.:2460400-11-5
Add to Inquiry
LOCATIONS

Service location

Taipei, New Taipei, Keelung / Yilan / Hualien
Inquiry Cart

Your inquiry Cart total 0 items

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
Manage Cookies

Privacy Preference Center

In accordance with the EU General Data Protection Regulation, we are committed to protecting your personal data and providing you with control over your personal data.
By clicking "Accept All," you allow us to place cookies to enhance your experience on this website, help us analyze website performance and usage, and enable us to deliver relevant marketing content. You can manage your cookie settings below. Clicking "Confirm" means you agree to the current settings.
View Privacy Policy

Manage Consent Settings

Necessary Cookies

Enable all
The operation of the website relies on these cookies, and you cannot disable them in the system. These cookies are usually set based on the actions you take (i.e., service requests), such as setting privacy preferences, logging in, or filling out forms. You can set your browser to block or prompt you about these cookies, but this may cause some website functions to stop working.